Butterfly Network: Behind The Big Rally (NYSE:BFLY)
Seeking Alpha· 2025-12-29 02:34
Author's note: I present and update my best small-cap Busted IPO stock ideas only to subscribers of my exclusive marketplace, The Busted IPO Forum . Try a free 2-week trial today by clicking HERE .Shares of ultrasound device concern Butterfly Network, Inc. ( BFLY ) have doubled since announcing the launch of Compass AI, aimed at improving workflows on November 17, 2025. The company's novel approach to its handheld, single-probe, full-body ultrasound leverages semiconductors as opposed toThe Busted IPO Forum ...
3 Supercharged Growth Stocks to Buy and Hold Into the 2030s
Yahoo Finance· 2025-12-29 02:33
亚马逊 (Amazon) - 为巩固电商护城河,公司在仓库部署了超过100万台机器人,管理层预计此举每年可节省高达40亿美元的履约成本[1] - 通过机器人效率提升及转向区域化仓储模式,预计到2030年零售板块的营业利润率将显著提升[1] - 公司正在整个生态系统大力投资人工智能,2025年计划资本支出预计达1250亿美元[2] - 其不断增长的AI生态系统包括自研定制芯片,如用于AI模型训练的Trainium和用于运行模型的Inferentia,旨在以比英伟达等竞争对手更低的成本提供高性能[2] - 广告是公司增长最快的板块,2025年该板块年化收入预计将超过600亿美元[3] - 通过利用其独特的第一方数据,并通过Prime Video和流媒体合作伙伴关系拓展品牌广告,广告业务有望在几年内轻松达到年收入1000亿美元[3] - 亚马逊云科技 (AWS) 是公司主要的利润引擎,目前约占全球云基础设施市场的30%[4] - 公司第三季度总收入为1802亿美元,同比增长13%;AWS部门销售额同比增长20%[7] - 第三季度营业利润为174亿美元,与去年同期持平,但包含了25亿美元的FTC和解金和18亿美元的遣散费,剔除这些因素后应为217亿美元[7] - 第三季度净利润同比增长38%,达到212亿美元[7] - 过去三年,公司股票为投资者带来了接近173%的总回报;过去十年,总回报超过600%[5] 福泰制药 (Vertex Pharmaceuticals) - 公司拥有强大的囊性纤维化 (CF) 药物专营权,并在利润丰厚的罕见病药物市场不断扩大立足点,过去10年回报率约为90%[8] - 公司在治疗CF根本病因的药物市场近乎垄断,其关键产品专利将延续至2030年代末,因此拥有稳定且高利润的财务基础[8] - 公司正通过针对肾脏疾病、疼痛管理和1型糖尿病等庞大且服务不足市场的多个后期临床开发项目,积极实现产品组合多元化[9] - 公司资产负债表稳健,债务低,利润率习惯性保持高位(超过30%),并产生大量自由现金流,这为其资助研发和进行战略收购提供了灵活性[9] - 截至2025年第三季度末,公司拥有约120亿美元的现金和投资[9] - 公司正在积极推出Casgevy,这是首个基因编辑疗法,是与CRISPR Therapeutics合作开发,用于镰状细胞病和输血依赖性β地中海贫血的功能性治愈方法[10] - 公司与CRISPR Therapeutics正通过授权治疗中心和确保多国报销协议来扩大Casgevy的可及性,该疗法已在美国、欧盟和英国获批用于12岁及以上符合条件的患者[10] - 另一项正在进行的主要产品是Journavx,一种用于中重度急性疼痛的非阿片类药物,截至2025年10月中旬,该药处方量已超过30万份,并于当年1月获FDA批准在美国使用[11] - 公司正在推进其候选药物inaxaplin(用于APOL1介导的肾病)和povetacicept(用于IgA肾病)的研发,两种疗法均处于针对各自适应症的后期临床开发阶段[12] - 公司已于2025年9月完成了inaxaplin全球2/3期AMPLITUDE试验中期分析队列的入组,计划在该队列治疗48周后进行中期分析,若结果积极,可能成为在美国寻求加速批准的基础[12] - FDA已授予povetacicept用于IgA肾病的突破性疗法认定,如果36周中期分析数据积极,公司有望在2026年上半年在美国提交加速批准申请[13] - 另一项值得关注的后期试验候选药物是zimislecel,这是一种使用干细胞衍生胰岛细胞、潜在的一次性功能性治愈1型糖尿病的方法,3期试验正在继续入组和给药患者,目标是在一年无胰岛素随访后提交批准申请[13] - 2026年和2027年,公司可能会有多项新的监管申请和批准[14] - 公司2025年第三季度营收超过30亿美元,同比增长11%;当季净利润为11亿美元[14] TJX公司 (TJX Companies) - 公司过去五年股价上涨近150%,凭借其创新有效的商业模式,增长超过许多同行零售商[15] - 公司的低价商业模式,即以大幅折扣机会性采购品牌商品,并为购物者创造寻宝体验,已被证明在各种经济周期和竞争威胁(包括电子商务的兴起)中具有韧性[15] - 管理层设定的长期目标是全球门店数量达到7000家,而截至2026财年第三季度末为5191家以上,因此在现有市场和新目标市场都有巨大的实体增长空间[16] - 与传统零售商拥有季节性库存不同,TJX门店每周多次接收新货,以创造不断变化的库存,这鼓励了喜欢寻找隐藏好物的购物者频繁重复光顾[16] - 商品组合的不可预测性创造了冒险和奖励感,且商品通常独特且销售迅速,激励购物者完成购买[17] - 许多TJX品牌在线存在有限或根本没有在线业务,这也促使消费者亲自前往其实体店购物[17] - 公司吸引了所有收入阶层的广泛消费者,在2025年当前经济环境下,随着注重成本的消费者从全价百货商店转向低价选择,TJX蓬勃发展[17] - 其门店部门间往往没有固定墙壁,这使得经理可以根据当前趋势或当地消费者需求快速扩大或收缩品类[18] - 公司拥有超过21000家全球供应商,其巨大的购买力确保了其成为品牌商寻求谨慎清理库存并保持货架上有受欢迎品牌的首选合作伙伴[18] - 公司在2026财年第三季度表现良好,每股收益和营收均超出华尔街预期,报告每股收益1.28美元,营收151亿美元,分别同比增长12%和7%[19] - 公司当季通过股票回购和股息向股东返还了11亿美元[19] - 公司支付股息,基于当前股价收益率约为1%,并且近三十年来每年都在增加股息[20]
Banks Are Unanimously Bearish On Oil – Is It The Contrarian Opportunity For 2026? - ConocoPhillips (NYSE:COP), United States Oil Fund (ARCA:USO)
Benzinga· 2025-12-29 02:30
Oil is closing 2025 as one of the negative-performing assets. Despite starting the year with a rally, oil's movement soon became typical bear-market dynamics. Consistent price decline interrupted by volatile, sharp double-digit rallies.Still, even in that environment, oil majors saw significant performance discrepancies. ConocoPhillips (NYSE:COP) lost 8.3% year-to-date, while Exxon Mobil (NYSE:XOM) squeezed a double-digit gain of over 11%.Going into 2026, oil has become one of the most consensus-bearish ass ...
Why Chart Industries Just Became an $88 Million Bet and 11% Position for a Global Macro Fund
Yahoo Finance· 2025-12-29 02:30
The company leverages its expertise in cryogenic and heat transfer technologies to serve critical infrastructure and specialty applications, supporting energy transition initiatives and industrial efficiency. Its broad product range and global service network position Chart Industries as a key partner for customers seeking advanced solutions in rapidly evolving markets.The company generates revenue through the sale of capital equipment, process technology, aftermarket services, and equipment leasing, with a ...
3 veterans of 'The Big Short' all say they're making this big macro bet for 2026
Yahoo Finance· 2025-12-29 02:30
Spencer Platt/Getty Images Years after shorting the housing market, three traders featured in 'The Big Short,' have new ideas. Danny Moses, Vinny Daniel, and Porter Collins all have similar views heading into 2026. Though all three expressed it differently, the three traders have the same macro view. Michael Burry gets a lot of attention these days, but there were a handful of other traders who also saw the collapse of US housing market coming from a mile away. Three of them told Business Insider ...
You Can Do Way Better Than Truist Financial Stock. Buy and Hold This Forever, Instead.
The Motley Fool· 2025-12-29 02:25
Truist was formed through the merger of BB&T and SunTrust in 2019.In 2019, two strong regional banks, BB&T and SunTrust, announced one of the largest bank mergers of equals in many years, at least at the time. Eventually, the pro forma institution also adopted a new name, Truist (TFC 0.26%), to establish a new brand that better represented the new entity. The pitch for the massive merger was simple in theory: deliver best-in-class efficiency and returns.More than six years later, that has yet to be accompli ...
California tech founders unload on a proposed state wealth tax that already has some billionaires preparing an escape. ‘I am screwed for life’
Yahoo Finance· 2025-12-29 02:22
A proposed wealth tax aimed at billionaires hasn’t yet qualified for California’s ballot, but it’s already sparked intense pushback from tech founders in the state. It started when the New York Times reported that venture capitalist Peter Thiel and Google cofounder Larry Page were looking into leaving California in case the tax becomes law. Democratic Rep. Ro Khanna, who represents part of Silicon Valley, flagged the story on X and echoed President Franklin Roosevelt by adding “I will miss them very mu ...
Here’s What Dan Ives Think About Microsoft Corporation (MSFT)
Yahoo Finance· 2025-12-29 02:20
核心观点 - 韦德布什证券分析师Dan Ives认为微软是2026年前最值得买入的高质量股票之一 投资者低估了微软及其Azure云业务的增长潜力 [1] - 分析师维持对微软的“增持”评级 目标价为625美元 意味着较当前水平有超过28%的上涨空间 [4] 业务增长与市场动态 - 过去一个月 公司交易量加速了20%至25% 这得益于人工智能用例的最终爆发 [2] - 在超大规模云服务商中 微软是最被忽视和最不受重视的公司 [2] - 需求与供给比率高达12比1 表明存在巨大的增长空间 [3] 财务预期与估值 - 市场普遍对微软2026年的增长数据预测不足 低估幅度至少为15%至20% [3] - 公司预计将于1月份发布财报 2026年被视作其关键年份 [2]
$92 Million Bet: Why This Fund Made CyberArk a 12% Portfolio Position Amid a Booming Stock Rally
The Motley Fool· 2025-12-29 02:20
CyberArk’s fundamentals are accelerating faster than its stock, and this filing hints at why some investors see more upside even after a big run.São Paulo-based Absolute Gestao de Investimentos Ltda. initiated a new position in CyberArk Software Ltd. (CYBR +0.62%), adding $92.23 million in the third quarter, according to a November 13 SEC filing.What HappenedAccording to an SEC filing dated November 13, Absolute Gestao de Investimentos disclosed a new stake in CyberArk Software Ltd. (CYBR +0.62%), purchasin ...
Meta Platforms (META) Set to Release Two New AI Developments in 2026
Yahoo Finance· 2025-12-29 02:18
Meta Platforms, Inc. (NASDAQ:META) is one of the Best Quality Stocks to Buy Before 2026. According to a report by The Wall Street Journal released on December 18, Meta Platforms, Inc. (NASDAQ:META) is set to release two new and significant AI developments in 2026. The company is developing its next large language model called Avocado, along with a new image and video generation AI model called Mango. The chief AI officer of Meta, Alexandr Wang, noted that these models are expected to be launched in the ...